Organization and Description of Business (Details Narrative) |
Apr. 16, 2021
$ / shares
shares
|
|---|---|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
| Exchange ratio price per shares | $ 0.7718 |
| Supera Pharmaceuticals Inc [Member] | Asset Purchase Agreement [Member] | |
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
| Stock issued during period, shares, acquisitions | shares | 33,937,909 |
| MyMD Pharmaceuticals (Florida), Inc [Member] | |
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |
| Common Stock, par value | $ 0.001 |
| Exchange ratio price per shares | $ 0.7718 |
| Stockholders' Equity, Reverse Stock Split | 1-for-2 reverse stock split |
| X | ||||||||||
- Definition Exchange ratio price per shares. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|